Overview
Daniel Fraughen practices in Dublin, Ireland. Mr. Fraughen is rated as a Distinguished expert by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Subcutaneous Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), Emphysema, and Chronic Obstructive Pulmonary Disease (COPD).
His clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Alpha-1 Antitrypsin Deficiency (AATD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Alpha-1 Antitrypsin Deficiency (AATD)Mr. Fraughen isDistinguished. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- EmphysemaMr. Fraughen isDistinguished. Learn about Emphysema.
- Subcutaneous EmphysemaMr. Fraughen isDistinguished. Learn about Subcutaneous Emphysema.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)Mr. Fraughen isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- Chronic Obstructive Pulmonary Disease (COPD)
- CirrhosisMr. Fraughen isExperienced. Learn about Cirrhosis.
- COVID-19Mr. Fraughen isExperienced. Learn about COVID-19.